Differences between distributions were evaluated with the KolmogorovSmirnov test
At present, the GLP-1 receptor agonists exendin-4 (Exenatide, Byetta , Bydureon ) (44, 45), liraglutide (Victoza ) (46), albiglutide [Eperzan (EU) Tanzeum (US)] (47, 48), dulaglutide (Trulicity ) (49), lixisenatide (Lyxumia , Adlyxin ) (50), semaglutide (Ozempic , Rybelsus ) (51, 52), are approved to treat T2DM (53) (see Table 1)
This applies even to cancers considered in remission
Vous ne serez jamais seul dans votre parcours : chaque tape est explique, chaque repas est planifi
AI empowerment was reflected in the whole research design and tested in the study area
Pioneer 1: Randomized clinical trial of the efficacy and safety of oral semaglutide monotherapy in comparison with placebo in patients with type 2 diabetes